, 1 yet two to three people in England and Wales die every year from the disease. Severe forms are associated with a very high mortality rate. Diagnosis is based on epidemiological history, clinical features, and investigations. It is often missed and easily overlooked because of the lack of awareness and the inability to obtain early laboratory confirmation. Adequate antibody titres appear only after a period of 5 -7 days 2 and, in the UK, the specimen needs to be sent to the reference laboratory at Hereford. Leptospirosis should be a differential diagnosis in an acutely ill patient with appropriate risk factors and symptomatology. We present a patient of an uncommon presentation of leptospirosis.
A 59-yr-old male attended the hospital with a 5-day history of fever, lethargy, body pain, headache, productive cough, and decreased appetite. He lived independently, smoked 30 cigarettes a day, and was keen on fishing in the nearby canal. He was in good health with no significant past medical or surgical history and had not recently travelled outside the UK.
On examination, he was alert, oriented, and icteric. Temperature was 37.78C, heart rate 109 beats min
21
, arterial pressure 93/53 mm Hg, and well-perfused peripheries. His ventilatory frequency was 19 min 21 with an oxygen saturation of 96% on room air. On auscultation, his heart sounds were normal and air entry were equal on both lungs with occasional scattered wheeze.
Initial investigations revealed a white cell count of 7. There was significant pulmonary bleeding for the first 4 days and his platelets were low; hence, activated protein C was not considered. He required sedation, and ventilatory support with lung protection strategy for 7 days before sedation and noradrenaline were able to be weaned off. A percutaneous tracheostomy was performed on day 7. Chest X-rays were compatible with ARDS and started to improve after 1 week. He was weaned slowly after more than 19 days and discharged to a medical ward on day 26.
The initial result for leptospirosis was negative. We sent a second specimen after 6 days, which resulted positive for leptospirosis, MAT positive at 1:640, ELISA IgM positive at 1:1280, and the infecting organism was reported as Leptospiro icterohaemorrhagiae. The appropriate health authorities were informed.
Leptospirosis is transmitted to humans usually by contact with soil or water contaminated with the urine of rats, cattle, rodents, and other wild animals. The disease usually presents as flu-like illness with mild hepatic and renal impairment. Severe forms of leptospirosis are characterized by severe hepato -renal dysfunction, mental status changes, haemorrhagic diathesis, and rarely with multiorgan dysfunction. Pulmonary involvement is not uncommon (20 -70%), 3 but symptoms are usually mild without sequelae. ARDS requiring artificial ventilation is very rare and has a high mortality rate of up to 51%.
4 This is often associated with pulmonary haemorrhage because of endothelial damage.
5 6 In our patient, the progression to haemorrhagic ARDS was very rapid. Early recognition and institution of appropriate antibiotics is known to reduce the mortality. To conclude, clinicians need to be aware of the possibility of leptospirosis even if the illness presents with unusual clinical features. Elicitation of good history from the patient and a high level of suspicion are paramount in identifying this rare but potentially fatal disease. This condition should be considered in the differential diagnosis of all acutely ill patients with relevant history, and clinical manifestation and appropriate antibiotics should be started early. Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients
Editor-Despite advances in supportive care, the mortality rate in patients with severe sepsis continues to exceed 30%. Sedation is an important part of the therapy of critically ill patients in ICU. Although midazolam and dexmedetomidine are used for sedation in the ICU, there are limited data on its effects on inflammatory responses and gastric intramucosal pH. We studied the effect of midazolam and dexmedetomidine on the inflammatory responses [tumour necrosis factor-a (TNF-a), interleukin (IL)-1b, and IL-6] and gastric intramucosal pH in critically ill patients receiving sedation. The Regional Committee on Medical Research Ethics approved the study, and written informed consent was obtained from the patients wherever possible, or from the next of kin. Critically ill patients with bacteriologically documented infections were included in the study if they met at least two of the criteria of sepsis, defined by the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. 1 Exclusion criteria were known allergy to midazolam or dexmedetomidine, possible or confirmed pregnancy, haemodynamic instability, heart, liver and renal failure, and patients with known or suspected brain death. The acute physiology and chronic health evaluation (APACHE II) was employed to determine the initial severity of illness.
